Delphia (USA)’s Claritev Corp CTEV Stock Holding History

Delphia (USA)’s Portfolio CTEV Stock Details CTEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-952	Closed	-$169K	–	417
2021 Q4	$169K	Buy	+952	New	+$170K	0.18%	230

Other funds holding CTEV

HFCIV

H&F Corporate Investors VIII San Francisco, California $133M AUM 24.42% 1-Year Est. Return

PIF

Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $37.9B AUM 7.98% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CPV Partners Stamford, Connecticut $274M AUM 43.74% 1-Year Est. Return

BPCM

Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Delphia (USA)'s CTEV Position: Q1 2022 in Review

Delphia (USA) sold out of Claritev Corp (CTEV) in Q1 2022, closing a stake of 952 shares — an estimated $169K sold.

Delphia (USA) first reported a position in CTEV in Q4 2021 and held it in 1 quarter. The position peaked at $169K in Q4 2021. 127 funds tracked by Wall St. Rank hold CTEV as of Q1 2022.

Delphia (USA) reported no remaining Claritev Corp position as of Q1 2022 after selling out during the quarter.
Delphia (USA) sold 952 Claritev Corp shares in Q1 2022, an estimated $169K.
Delphia (USA) first reported a position in Claritev Corp in Q4 2021 and held it in 1 quarter.
Delphia (USA)'s Claritev Corp position peaked at $169K in Q4 2021.
127 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.